AU2003218147A1 - Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa - Google Patents
Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa Download PDFInfo
- Publication number
- AU2003218147A1 AU2003218147A1 AU2003218147A AU2003218147A AU2003218147A1 AU 2003218147 A1 AU2003218147 A1 AU 2003218147A1 AU 2003218147 A AU2003218147 A AU 2003218147A AU 2003218147 A AU2003218147 A AU 2003218147A AU 2003218147 A1 AU2003218147 A1 AU 2003218147A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- cyclopropylglycinyl
- piperazine
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36852302P | 2002-04-01 | 2002-04-01 | |
| US60/368,523 | 2002-04-01 | ||
| PCT/US2003/007794 WO2003084929A1 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003218147A1 true AU2003218147A1 (en) | 2003-10-20 |
Family
ID=28791889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003218147A Abandoned AU2003218147A1 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
Country Status (24)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6834308B1 (en) | 2000-02-17 | 2004-12-21 | Audible Magic Corporation | Method and apparatus for identifying media content presented on a media playing device |
| US7363278B2 (en) | 2001-04-05 | 2008-04-22 | Audible Magic Corporation | Copyright detection and protection system and method |
| US8972481B2 (en) | 2001-07-20 | 2015-03-03 | Audible Magic, Inc. | Playlist generation method and apparatus |
| DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
| WO2018093716A1 (en) * | 2016-11-18 | 2018-05-24 | Merck Sharp & Dohme Corp. | FACTOR XIIa INHIBITORS |
| EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999011658A1 (en) | 1997-08-29 | 1999-03-11 | Proteus Molecular Design Ltd. | Meta-benzamidine derivatives as serin protease inhibitors |
| CA2375920A1 (en) | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Compounds |
| CA2383008A1 (en) | 1999-06-14 | 2000-12-21 | Amanda Jane Lyons | Compounds |
| GB0030305D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030306D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030303D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| TWI257389B (en) | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
| US7265121B2 (en) * | 2001-07-26 | 2007-09-04 | Eli Lilly And Company | Chemical compounds |
-
2003
- 2003-03-24 PL PL03373066A patent/PL373066A1/xx unknown
- 2003-03-24 EA EA200401290A patent/EA007300B1/ru not_active IP Right Cessation
- 2003-03-24 EP EP03714138A patent/EP1492767B1/en not_active Expired - Lifetime
- 2003-03-24 WO PCT/US2003/007794 patent/WO2003084929A1/en not_active Ceased
- 2003-03-24 NZ NZ535402A patent/NZ535402A/en unknown
- 2003-03-24 AU AU2003218147A patent/AU2003218147A1/en not_active Abandoned
- 2003-03-24 AT AT03714138T patent/ATE303990T1/de not_active IP Right Cessation
- 2003-03-24 KR KR10-2004-7015486A patent/KR20040094892A/ko not_active Ceased
- 2003-03-24 JP JP2003582128A patent/JP2005531529A/ja active Pending
- 2003-03-24 CA CA002478340A patent/CA2478340A1/en not_active Abandoned
- 2003-03-24 IL IL16401803A patent/IL164018A0/xx unknown
- 2003-03-24 MX MXPA04009640A patent/MXPA04009640A/es active IP Right Grant
- 2003-03-24 UA UA20041008649A patent/UA76849C2/uk unknown
- 2003-03-24 ES ES03714138T patent/ES2248737T3/es not_active Expired - Lifetime
- 2003-03-24 CN CNB038074141A patent/CN1288135C/zh not_active Expired - Fee Related
- 2003-03-24 DE DE60301569T patent/DE60301569T2/de not_active Expired - Fee Related
- 2003-03-24 BR BR0308870-7A patent/BR0308870A/pt not_active IP Right Cessation
- 2003-03-24 DK DK03714138T patent/DK1492767T3/da active
- 2003-03-24 HR HR20040900A patent/HRP20040900B1/xx not_active IP Right Cessation
- 2003-03-24 US US10/486,138 patent/US7166606B2/en not_active Expired - Fee Related
-
2004
- 2004-09-15 ZA ZA200407418A patent/ZA200407418B/en unknown
- 2004-09-24 CR CR7497A patent/CR7497A/es unknown
- 2004-09-29 EC EC2004005329A patent/ECSP045329A/es unknown
- 2004-10-29 NO NO20044688A patent/NO20044688L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2478340A1 (en) | 2003-10-16 |
| UA76849C2 (uk) | 2006-09-15 |
| HRP20040900B1 (en) | 2006-02-28 |
| WO2003084929A1 (en) | 2003-10-16 |
| EA007300B1 (ru) | 2006-08-25 |
| BR0308870A (pt) | 2005-01-04 |
| PL373066A1 (en) | 2005-08-08 |
| DE60301569D1 (de) | 2005-10-13 |
| KR20040094892A (ko) | 2004-11-10 |
| EA200401290A1 (ru) | 2005-02-24 |
| ZA200407418B (en) | 2005-09-15 |
| DK1492767T3 (da) | 2005-11-28 |
| EP1492767A1 (en) | 2005-01-05 |
| ES2248737T3 (es) | 2006-03-16 |
| US7166606B2 (en) | 2007-01-23 |
| HK1070363A1 (en) | 2005-06-17 |
| CR7497A (es) | 2005-01-17 |
| JP2005531529A (ja) | 2005-10-20 |
| HRP20040900A2 (en) | 2004-12-31 |
| WO2003084929A8 (en) | 2004-05-21 |
| NZ535402A (en) | 2006-02-24 |
| ATE303990T1 (de) | 2005-09-15 |
| MXPA04009640A (es) | 2005-01-11 |
| NO20044688L (no) | 2004-10-29 |
| ECSP045329A (es) | 2004-11-26 |
| CN1288135C (zh) | 2006-12-06 |
| DE60301569T2 (de) | 2006-06-14 |
| IL164018A0 (en) | 2005-12-18 |
| EP1492767B1 (en) | 2005-09-07 |
| US20050096328A1 (en) | 2005-05-05 |
| CN1642914A (zh) | 2005-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1819693B1 (en) | Antithrombotic diamides | |
| US4873253A (en) | Phenylalanine derivative and proteinase inhibitor | |
| CZ293912B6 (cs) | Karboxamidový derivát pyrrolidinuŹ piperidinu hexahydroazepinuŹ jeho použití a farmaceutická kompozice na jeho bázi | |
| EP1492767B1 (en) | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa | |
| US7427632B2 (en) | Factor Xa inhibitors | |
| AU759631B2 (en) | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders | |
| EP1409479B1 (en) | 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists | |
| US7115609B2 (en) | Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases | |
| US5610308A (en) | Process for preparing intermediates for thrombin inhibitors | |
| HK1070363B (en) | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa | |
| EP1455787B1 (en) | Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders | |
| MXPA00004201A (en) | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |